Skip to content
Screener

Intellia Therapeutics NTLA Operating Lease Liability - Undiscounted Excess Amount

Operating Lease Liability - Undiscounted Excess Amount at other companies

Prime Medicine logo
Prime MedicinePRME
$61.15M-18.7%
Immix Biopharma, Inc. logo
Immix Biopharma, Inc.IMMX
$356.67K-18.3%
Artiva Biotherapeutics, Inc. logo
Artiva Biotherapeutics, Inc.ARTV
$1.24M-47.9%

Segments

By geography

See full
Tech Square Lease$189.1M+20.6%

Other financials

Income statement

See full
Revenue$7.7M-46.2%
Operating income-$112.8M-2.5%
Net income-$106.6M-5.3%
EPS (diluted)-$0.80+18.4%

Balance sheet

See full
Cash & equivalents$106.1M-32.0%
Total debt$73.4M-28.4%
Total equity$727.7M+202%
Total assets$857.2M-4.6%

Cash flow

See full
Operating cash flow-$83.1M+16.6%
CapEx$1.8M+657%
Free cash flow-$84.9M+15.0%

Valuation

See full
Market cap$1.67B+45.7%
Enterprise value$1.64B+49.8%
P/S28×+6.4×

Profitability

See full
Operating margin-711.7%-149pp
Net margin-672.2%-139pp
FCF margin-586%-123pp

Returns & leverage

See full
Return on equity-56.3%-1.5pp
Debt / equity0.1×—
Current ratio6.6×+1.5×

FAQ

What does operating lease liability - undiscounted excess amount mean?
This represents the difference between the total undiscounted future lease payments and the present value of those payments recorded on the balance sheet. It effectively quantifies the interest component embedded within operating lease obligations. It is a measure of the financing cost inherent in the lease portfolio.